Risk Factors Update Summary
- Net loss decreased from $12 million to $5 million, with operating cash flow deficit decreasing from $7 million to $3 million.
- Accumulated deficit increased from $92 million to $98 million, while working capital decreased from $10 million to $5 million.
- Prospectus supplement filed for sales of up to $865,889 of shares, with approximately $0.8 million remaining available.
- Sales agreement with AGP increased from $22.5 million to $50.8 million, with approximately $0.1 million received through the AGP Sales Agreement.
- Number of shares reserved for issuance upon exercise or conversion of outstanding warrants increased from approximately 459,535 to 459,535.
- Number of shares sold increased from 119,656 to 192, with an additional $3 million available for future sales.
- Number of shares reserved for issuance upon exercise of outstanding stock options increased from 232,744 to 232,744.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1043961&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.